POOR OUTCOMES OF NPM1 MUTATED AML IN BRAZIL REGARDLESS OF TRADITIONAL RISK FACTORS AND RECENT INCORPORATION OF MOLECULAR MONITORING MVA Azevedo; FR Mendes; RCB Melo; L Nardinelli; I Bendit; EDRP Velloso; V Rocha; EM Rego; WF Silva;

COMPARISON BETWEEN MULTIPLEX LIGATION-DEPENDENT PROBE AMPLIFICATION (MLPA) AND CYTOGENETICS FOR VALIDATION OF CHROMOSOMAL ABERRATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA L Nardinelli; RR Giorgi; ARL Ruiz; AM Leal; PBF Pinotti; AMC Ferreira; EDRP Velloso; V Buccheri; V Rocha; I Bendit;

CARACTERÍSTICAS CLÍNICAS E LABORATORIAIS DE 24 PACIENTES PORTADORES DE MASTOCITOSE SISTÊMICA (MS): ESTUDO UNICÊNTRICO LL Marchi; L Nardinelli; L Bassoli; MD Jacomassi; EA Rosseto-Welter; V Rocha; EDRP Velloso;